Peg has served as Synthekine’s Vice President of Development Operations since January 2023. With more than 30 years of experience in the biotech and pharma industries, Peg brings her extensive background in oncology clinical development, 20 years of which were spent at Genentech and Merck. As an operational trialist across varying molecule platforms including small molecules, bispecifics, and most recently, cell and gene therapy, Peg has led operational teams and collaborated across multiple functions to transform resources into results that provide value and benefit to patients. Prior to Synthekine, Peg served as an Executive Director of Clinical Operations, Immuno-oncology at CRISPR Therapeutics. She has a B.S. in Nutrition Science from University of California, Davis and has been trained as a registered dietitian at Brigham and Women’s Hospital in Boston, Massachusetts.
Copyright 2023 – Synthekine